Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
BJU International|May 9, 2012
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?Tom Pickles, Jeremy Hamm, W James Morris, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 28, 2008
Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meetingMichael Sia, Tom Pickles, Gerard Morton, et al.
Brachytherapy|July 8, 2010
Comparative 5-year outcomes of brachytherapy and surgery for prostate cancerTom Pickles, W James Morris, Michael W Kattan, et al.
American Journal of Ophthalmology|March 4, 2014
Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye diseasePari N Shams, Roy Ma, Tom Pickles, et al.
The Canadian Journal of Urology|March 22, 2005
Prostate cancer radiotherapy 2002: the way forwardHimu Lukka, Tom Pickles, Gerard Morton, et al.
Brachytherapy|March 3, 2015
Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicityJim N Rose, Juanita M Crook, Tom Pickles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Validating the interval to biochemical failure for the identification of potentially lethal prostate cancerMark K Buyyounouski, Tom Pickles, Larry L Kestin, et al.
Journal of Oncology|August 25, 2015
The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, CanadaMargot K Davis, Jennifer L Rajala, Scott Tyldesley, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mLEric Berthelet, Tom Pickles, Kenny Won Jae Lee, et al.
Brachytherapy|October 16, 2013
Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy patientsW James Morris, Ingrid Spadinger, Mira Keyes, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
BJU International|May 9, 2012
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?Tom Pickles, Jeremy Hamm, W James Morris, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 28, 2008
Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meetingMichael Sia, Tom Pickles, Gerard Morton, et al.
Brachytherapy|July 8, 2010
Comparative 5-year outcomes of brachytherapy and surgery for prostate cancerTom Pickles, W James Morris, Michael W Kattan, et al.
American Journal of Ophthalmology|March 4, 2014
Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye diseasePari N Shams, Roy Ma, Tom Pickles, et al.
The Canadian Journal of Urology|March 22, 2005
Prostate cancer radiotherapy 2002: the way forwardHimu Lukka, Tom Pickles, Gerard Morton, et al.
Brachytherapy|March 3, 2015
Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicityJim N Rose, Juanita M Crook, Tom Pickles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Validating the interval to biochemical failure for the identification of potentially lethal prostate cancerMark K Buyyounouski, Tom Pickles, Larry L Kestin, et al.
Journal of Oncology|August 25, 2015
The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, CanadaMargot K Davis, Jennifer L Rajala, Scott Tyldesley, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mLEric Berthelet, Tom Pickles, Kenny Won Jae Lee, et al.
Brachytherapy|October 16, 2013
Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy patientsW James Morris, Ingrid Spadinger, Mira Keyes, et al.
Pageof 14